Screening of Natural Compounds for CYP11A1 Stimulation Against Cell Renal Cell Carcinoma
CONCLUSIONS: This study indicates that the CYP11A1-overexpressing Caki-1 cell line is useful for screening drugs against kidney cancer. The two selected compounds could be utilized as lead compounds for anticancer drug discovery, and specifically for the development of antirenal cancer medication.PMID:38036976 | DOI:10.1186/s12575-023-00225-y
Source: Biological Procedures Online - Category: Molecular Biology Authors: Hien Thi My Ong Eda Ates Oh-Seung Kwon Min-Jung Kang Source Type: research
More News: Cancer | Cancer & Oncology | Cancer Therapy | Carcinoma | Cholesterol | Epithelial Cancer | Hormones | Kidney Cancer | Molecular Biology | Renal Cell Carcinoma | Study | Urology & Nephrology